We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Pomegranate Juice Lowers Cardiovascular Risk in Dialysis Patients

By HospiMedica International staff writers
Posted on 13 Dec 2011
Hemodialysis patients had significant improvement in their cardiovascular risk (CV) profile after consuming 300 cc of pomegranate juice weekly for a year, according to a new study. More...


Researchers at the Western Galilee Hospital (WGH; Nahariya, Israel) conducted a randomized, placebo-controlled clinical trial involving 101 hemodialysis patients randomized on a 2:1 ratio to receive 100 cc of pomegranate juice three times weekly, or a matching placebo. The primary endpoints were change in lipid profile--triglycerides, low-density lipoprotein (LDL), and high-density lipoprotein (HDL)--and change in blood pressure (systolic, diastolic, and number of medications). Subsequently, 26 patients in the placebo group and 41 in the pomegranate arm completed the 12-month study.

The results showed that triglyceride levels and systolic blood pressure declined significantly from baseline, and high-density lipoprotein (HDL) increased significantly; diastolic blood pressure did not change significantly in either group. In addition, consumption of pomegranate juice on a regular basis was associated with a 22.2% reduction in use of antihypertensive medications. In contrast, patients randomized to placebo had no significant changes in any of the parameters. The study was presented at the American Society of Nephrology (ASN) annual meeting, held during November 2011 in Philadelphia (PA, USA).

“Ongoing regular consumption of pomegranate juice may well lead to improved quality of life by reducing the high illness rate among dialysis patients,” said lead author and study presenter Batya Kristal, MD. “In the pomegranate arm, the parameters that improved did so within the first three months of the study, and either remained stable or continued to increase to the end of the trial.”

Pomegranate has a history of association with health benefits dating back to ancient times, ranging from improvement in various gastrointestinal (GI) conditions to ameliorating headaches associated with a hangover. There is evidence of antiviral, antibacterial, anti-inflammatory, and anticarcinogenic potential for pomegranate, as well as improvement in lipid profile, blood pressure, and heart function in patients with diabetes, hypertension, and heart disease. A possible explanation for the benefits is that pomegranate juice contains substantial concentrations of ascorbic and polyphenolic acids, and that pomegranate peel and pulp have large concentrations of antioxidants.

Related Links:
Western Galilee Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.